Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Tax Provision
Tibet Rhodiola Pharmaceutical Holding Co
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Tax Provision
-¥87.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-30%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Tax Provision
-¥4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-16%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Tax Provision
-¥1.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-12%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Tax Provision
-¥715.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-18%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Tax Provision
-¥596.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-19%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Tax Provision
-¥634.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-13%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Tax Provision?
Tax Provision
-87.9m
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Tax Provision amounts to -87.9m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Tax Provision growth rate?
Tax Provision CAGR 10Y
-30%
Over the last year, the Tax Provision growth was 0%. The average annual Tax Provision growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been -21% over the past three years , -27% over the past five years , and -30% over the past ten years .